She F - Search Results

1

The effects of renal impairment on the pharmacokinetics, safety, and tolerability of naloxegol.

Bui K, She F, Sostek M. Bui K, et al. Among authors: she f. J Clin Pharmacol. 2014 Dec;54(12):1375-82. doi: 10.1002/jcph.349. Epub 2014 Jul 1. J Clin Pharmacol. 2014. PMID: 24946021 Clinical Trial.

2

The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol.

Bui K, She F, Sostek M. Bui K, et al. Among authors: she f. J Clin Pharmacol. 2014 Dec;54(12):1368-74. doi: 10.1002/jcph.348. Epub 2014 Jun 27. J Clin Pharmacol. 2014. PMID: 24945932 Clinical Trial.

3

The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol.

Bui K, She F, Zhou D, Butler K, Al-Huniti N, Sostek M. Bui K, et al. Among authors: she f. J Clin Pharmacol. 2016 Apr;56(4):497-505. doi: 10.1002/jcph.613. Epub 2015 Nov 9. J Clin Pharmacol. 2016. PMID: 26248047 Clinical Trial.

4

Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects.

Bui K, She F, Hutchison M, Brunnström Å, Sostek M. Bui K, et al. Among authors: she f. Int J Clin Pharmacol Ther. 2015 Oct;53(10):838-46. doi: 10.5414/CP202276. Int J Clin Pharmacol Ther. 2015. PMID: 26329350 Free PMC article. Clinical Trial.

5

Effects of CYP3A Modulators on the Pharmacokinetics of Naloxegol.

Bui K, Zhou D, Sostek M, She F, Al-Huniti N. Bui K, et al. Among authors: she f. J Clin Pharmacol. 2016 Aug;56(8):1019-27. doi: 10.1002/jcph.693. Epub 2016 Feb 24. J Clin Pharmacol. 2016. PMID: 26678015 Clinical Trial.

6

Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study.

Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. Khan A, et al. Among authors: she f. Psychopharmacol Bull. 2011 May 15;44(2):5-31. Psychopharmacol Bull. 2011. PMID: 27738353 Free PMC article.

7

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.

Mezhebovsky I, Mägi K, She F, Datto C, Eriksson H. Mezhebovsky I, et al. Among authors: she f. Int J Geriatr Psychiatry. 2013 Jun;28(6):615-25. doi: 10.1002/gps.3867. Epub 2012 Oct 16. Int J Geriatr Psychiatry. 2013. PMID: 23070803 Clinical Trial.

8

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.

Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. Khan A, et al. Among authors: she f. Ann Clin Psychiatry. 2013 Nov;25(4):E7-22. Ann Clin Psychiatry. 2013. PMID: 24199224 Clinical Trial.

9

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.

Khan A, Atkinson S, Mezhebovsky I, She F, Leathers T, Pathak S. Khan A, et al. Among authors: she f. Ann Clin Psychiatry. 2014 Feb;26(1):3-18. Ann Clin Psychiatry. 2014. PMID: 24660224 Clinical Trial.

10

Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.

Merideth C, Cutler AJ, She F, Eriksson H. Merideth C, et al. Among authors: she f. Int Clin Psychopharmacol. 2012 Jan;27(1):40-54. doi: 10.1097/YIC.0b013e32834d9f49. Int Clin Psychopharmacol. 2012. PMID: 22045039 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters